John O’Brien. Council for Affordable Health Coverage via YouTube

Trump's key drug pric­ing ad­vi­sor O'Brien makes HHS ex­it

Less than a year af­ter be­ing ap­point­ed se­nior ad­vi­sor to the sec­re­tary for drug pric­ing re­form — John O’Brien — is leav­ing the HHS, the agency dis­closed on Mon­day.

O’Brien — who is a for­mer PhRMA lob­by­ist and has pre­vi­ous­ly worked with health in­sur­er Blue­Cross BlueShield and the CMS — was con­sid­ered one of the key ar­chi­tects of Pres­i­dent Trump’s drug pol­i­cy ini­tia­tives. He was pro­mot­ed to his po­si­tion in De­cem­ber 2018.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.